NasdaqGM - Delayed Quote USD

Adagene Inc. (ADAG)

2.6596 -0.0004 (-0.02%)
At close: May 15 at 4:00 PM EDT
2.6600 +0.00 (+0.02%)
After hours: May 15 at 4:14 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
18,111.4910
18,111.4910
9,292.7240
10,175.2580
700.9130
Operating Expense
41,831.3570
41,831.3570
93,213.4070
82,539.3470
43,852.5710
Operating Income
-23,719.8660
-23,719.8660
-83,920.6830
-72,364.0890
-43,151.6580
Net Non Operating Interest Income Expense
3,175.2650
3,175.2650
-315.8220
-287.5960
427.1230
Other Income Expense
3,289.6390
3,289.6390
4,723.7130
1,175.3630
327.2560
Pretax Income
-17,254.9620
-17,254.9620
-79,512.7920
-71,476.3220
-42,397.2790
Tax Provision
1,691.4080
1,691.4080
459.0550
1,701.6130
--
Net Income Common Stockholders
-18,946.3700
-18,946.3700
-79,971.8470
-73,206.4880
-42,645.3920
Diluted NI Available to Com Stockholders
-18,946.3700
-18,946.3700
-79,971.8470
-73,206.4880
-42,645.3920
Basic EPS
-0.44
--
-1.85
-1.82
-1.01
Diluted EPS
-0.44
--
-1.85
-1.82
-1.01
Basic Average Shares
43,790.0240
--
43,308.0670
40,025.6070
42,179.8200
Diluted Average Shares
43,790.0240
--
43,308.0670
40,025.6070
42,179.8200
Total Operating Income as Reported
-23,719.8660
-23,719.8660
-83,920.6830
-72,364.0890
-43,151.6580
Total Expenses
41,831.3570
41,831.3570
93,213.4070
82,539.3470
43,852.5710
Net Income from Continuing & Discontinued Operation
-18,946.3700
-18,946.3700
-79,971.8470
-73,177.9350
-42,397.2790
Normalized Income
-20,031.0215
-20,031.0215
-81,888.3408
-72,725.3408
-41,752.5860
Interest Income
4,283.0850
4,283.0850
377.5010
76.1660
629.2880
Interest Expense
1,107.8200
1,107.8200
693.3230
363.7620
202.1650
Net Interest Income
3,175.2650
3,175.2650
-315.8220
-287.5960
427.1230
EBIT
-16,147.1420
-16,147.1420
-78,819.4690
-71,112.5600
-42,195.1140
EBITDA
-14,938.6840
-14,938.6840
-77,369.9390
-69,987.5280
-41,336.7060
Reconciled Depreciation
1,208.4580
1,208.4580
1,449.5300
1,125.0320
858.4080
Net Income from Continuing Operation Net Minority Interest
-18,946.3700
-18,946.3700
-79,971.8470
-73,177.9350
-42,397.2790
Total Unusual Items Excluding Goodwill
1,446.2020
1,446.2020
2,555.3250
-603.4590
-644.6930
Total Unusual Items
1,446.2020
1,446.2020
2,555.3250
-603.4590
-644.6930
Normalized EBITDA
-16,384.8860
-16,384.8860
-79,925.2640
-69,384.0690
-40,692.0130
Tax Rate for Calcs
0.0003
0.0003
0.0003
0.0003
--
Tax Effect of Unusual Items
361.5505
361.5505
638.8313
-150.8648
--
12/31/2020 - 2/9/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AVBP ArriVent BioPharma, Inc.
19.50
+5.63%
 
CNTB Connect Biopharma Holdings Limited
1.8200
-6.19%
 
CNTA Centessa Pharmaceuticals plc
8.79
-2.77%
 
SNSE Sensei Biotherapeutics, Inc.
1.4900
-1.32%
 
BCAB BioAtla, Inc.
3.0000
+14.94%
 
IPHA Innate Pharma S.A.
2.5063
+0.05%
 
THRD Third Harmonic Bio, Inc.
12.92
+0.08%
 
FNCH Finch Therapeutics Group, Inc.
2.1000
+8.25%
 
RKVTF RAKOVINA THERAPEUTICS INC
0.0600
0.00%
 
ANRO Alto Neuroscience, Inc.
13.84
-2.26%